- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 379645, 6 pages
Impact of Integrated Amrita Meditation Technique on Adrenaline and Cortisol Levels in Healthy Volunteers
1Department of Physiology, Amrita Institute of Medical Sciences, Amrita Lane, Ponekkara P.O., Cochin 682 041, Kerala, India
2Department of Biochemistry, Amrita Institute of Medical Sciences, Amrita Lane, Ponekkara P.O., Cochin 682 041, Kerala, India
3Department of Biostatistics, Amrita Institute of Medical Sciences, Amrita Lane, Ponekkara P.O., Cochin 682 041, Kerala, India
4Department of Endocrinology, Amrita Institute of Medical Sciences, Amrita Lane, Ponekkara P.O., Cochin 682 041, Kerala, India
Received 9 September 2010; Revised 27 November 2010; Accepted 8 January 2011
Copyright © 2011 Balakrishnan Vandana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- H. Selye, “A syndrome produced by diverse nocuous agents,” Nature, vol. 138, no. 3479, p. 32, 1936.
- H. Selye, “Forty years of stress research: principal remaining problems and misconceptions,” Canadian Medical Association Journal, vol. 115, no. 1, pp. 53–56, 1976.
- R. Bandler, K. A. Keay, N. Floyd, and J. Price, “Central circuits mediating patterned autonomic activity during active vs. passive emotional coping,” Brain Research Bulletin, vol. 53, no. 1, pp. 95–104, 2000.
- A. B. Newberg and J. Iversen, “The neural basis of the complex mental task of meditation: neurotransmitter and neurochemical considerations,” Medical Hypotheses, vol. 61, no. 2, pp. 282–291, 2003.
- AC Bhakthivedanta Swami prabhupada, “Dhyana yoga chapter,” in Bhagawad Gita as It Is, pp. 273–320, Bhaktivedanta Book Trust, Mumbai, India, 2 edition, 2004.
- J. H. Woods, Yoga System of Patanjali, Kessinger, Kila, Mont, USA, 2003.
- P. Yogananda, Autobiography of a Yogi, Yogada Satsanga Society of India, Kolkota, India, 2006.
- R. K. Wallace, J. Silver, P. J. Mills, M. C. Dillbeck, and D. E. Wagoner, “Physiological effects of transcendental meditation,” Science, vol. 167, no. 3926, pp. 1751–1754, 1970.
- “Scientific research on Maharishi's Transcendental Meditation and TM-Sidhi Programme: Collected Papers,” Volumes 1–6, Maharishi Vedic University Press, Holland.
- D. W. Orme Johnson, “Autonomic stability and transcendental meditation,” Psychosomatic Medicine, vol. 35, no. 4, pp. 341–349, 1973.
- A. J. Arias, K. Steinberg, A. Banga, and R. L. Trestman, “Systematic review of the efficacy of meditation techniques as treatments for medical illness,” Journal of Alternative and Complementary Medicine, vol. 12, no. 8, pp. 817–832, 2006.
- R. H. Schneider, F. Staggers, C. N. Alexander et al., “A randomized controlled trial of stress reduction for hypertension in older African Americans,” Hypertension, vol. 26, no. 5, pp. 820–827, 1995.
- M. V. Rainforth, R. H. Schneider, S. I. Nidich, C. Gaylord-King, J. W. Salerno, and J. W. Anderson, “Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis,” Current Hypertension Reports, vol. 9, no. 6, pp. 520–528, 2007.
- R. H. Schneider, S. I. Nidich, J. W. Salerno et al., “Lower lipid peroxide levels in practitioners of the transcendental meditation program,” Psychosomatic Medicine, vol. 60, no. 1, pp. 38–41, 1998.
- M. Paul-Labrador, D. Polk, J. H. Dwyer et al., “Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease,” Archives of Internal Medicine, vol. 166, no. 11, pp. 1218–1224, 2006.
- J. Harte, “Psychoneuroendocrine concomitants of the emotional experience associated with running and meditation,” in Behavior and Immunity, A. J. Husband, Ed., pp. 43–57, CRC Press, Boca Raton, Fla, USA, 1992.
- A. L. Taylor, “Corticotropin-releasing hormone,” New England Journal of Medicine, vol. 319, no. 4, pp. 213–222, 1988.
- C. N. Alexander, M. V. Rainforth, and P. Gelderloos, “Transcendental Meditation, self actualization, and psychological health: a conceptual overview and statistical meta-analysis,” Journal of Social Behavior & Personality, vol. 6, no. 5, pp. 189–247, 1991.
- C. N. Alexander, P. Robinson, D. W. Orme-Johnson, et al., “The effects of Transcendental Meditation compared to other methods of relaxation in reducing risk factors, morbidity, and mortality,” Homeostasis, vol. 35, pp. 243–263, 1994.
- M. B. Ospina, K. Bond, M. Karkhaneh et al., “Meditation practices for health: state of the research,” Evidence Report/Technology Assessment, no. 155, pp. 1–263, 2007.
- E. Jacobson, “The technique of progressive relaxation,” The Journal of Nervous and Mental Disease, vol. 60, no. 6, pp. 568–578, 1924.
- R. Sudsuang, V. Chentanez, and K. Veluvan, “Effect of Buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time,” Physiology and Behavior, vol. 50, no. 3, pp. 543–548, 1991.
- R. Lang, K. Dehof, K. A. Meurer, and W. Kaufmann, “Sympathetic activity and transcendental meditation,” Journal of Neural Transmission, vol. 44, no. 1-2, pp. 117–135, 1979.
- J. R. Infante, M. Torres-Avisbal, P. Pinel et al., “Catecholamine levels in practitioners of the transcendental meditation technique,” Physiology and Behavior, vol. 72, no. 1-2, pp. 141–146, 2001.
- K. Eliasson, P. Hjemdahl, and T. Kahan, “Circulatory and sympatho-adrenal responses to stress in borderline and established hypertension,” Journal of Hypertension, vol. 1, no. 2, pp. 131–139, 1983.
- W. F. Ganong, Review of Medical Physiology, Lange, 22nd edition, 2007.
- R. R. Michaels, J. Parra, D. S. McCann, and A. J. Vander, “Renin, cortisol, and aldosterone during transcendental meditation,” Psychosomatic Medicine, vol. 41, no. 1, pp. 50–54, 1979.
- K. G. Walton, J. Z. Fields, D. K. Levitsky, D. A. Harris, N. D. Pugh, and R. H. Schneider, “Lowering cortisol and CVD risk in postmenopausal women: a pilot study using the transcendental meditation program,” Annals of the New York Academy of Sciences, vol. 1032, pp. 211–215, 2004.
- C. R. K. MacLean, K. G. Walton, S. R. Wenneberg et al., “Effects of the transcendental meditation program on adaptive mechanisms: changes in hormone levels and responses to stress after 4 months of practice,” Psychoneuroendocrinology, vol. 22, no. 4, pp. 277–295, 1997.
- C. R. K. MacLean, K. G. Walton, S. R. Wenneberg et al., “Altered responses of cortisol, GH, TSH and testosterone to acute stress after four months' practice of transcendental meditation (TM),” Annals of the New York Academy of Sciences, vol. 746, pp. 381–384, 1994.
- V. Bullen, “Salivary cortisol, stress and arousal following five weeks training in kinesthetic meditation to undergraduate students,” Journal of Holistic Healthcare, vol. 3, no. 3, pp. 34–38, 2006.
- P. Jin, “Changes in heart rate, noradrenaline, cortisol and mood during Tai Chi,” Journal of Psychosomatic Research, vol. 33, no. 2, pp. 197–206, 1989.